BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 7506123)

  • 1. Combinations of stem cell factor with other hematopoietic growth factors enhance growth and sensitivity to cytosine arabinoside of blast progenitors in acute myelogenous leukemia.
    Inatomi Y; Toyama K; Clark SC; Shimizu K; Miyauchi J
    Cancer Res; 1994 Jan; 54(2):455-62. PubMed ID: 7506123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of stem cell factor (SCF) on the in vitro growth of leukemic blast progenitors in acute non-lymphocytic leukemia.
    Nara N; Tanikawa S; Nagata K; Hamaguchi H; Tomiyama J
    Int J Hematol; 1993 Aug; 58(1-2):27-35. PubMed ID: 7693028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of mast cell growth factor on Ara-C mediated acute myeloid leukemia cell killing.
    Tafuri A; De Felice L; Mascolo MG; Valentini T; Petrucci MT; Petti MC
    Stem Cells; 1993 Jul; 11 Suppl 2():88-92. PubMed ID: 7691332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Enhanced sensitivity to cytosine arabinoside by combined stimulation of steel factor and GM-CSF in a factor-dependent leukemic cell line, MO7e--in terms of a possible clinical application to AML treatment].
    Gotoh A; Kawanishi Y; Kurosawa K; Miyazawa K; Ohtaka M; Aizawa S; Kimura Y; Yoshikawa O; Toyama K
    Rinsho Ketsueki; 1993 Jul; 34(7):821-8. PubMed ID: 7689660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of stem cell factor on leukemic progenitor cell growth and sensitivity to cytosine-arabinoside.
    Viallard JF; Grosset C; Lacombe F; David S; Mahon FX; Barbot C; Vianes I; Dupouy M; Reiffers J
    Leuk Res; 1996; 20(11-12):915-23. PubMed ID: 9009249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of basic and acidic fibroblast growth factors (bFGF and aFGF) on the growth of leukemic blast progenitors in acute myelogenous leukemia.
    Nara N; Kurokawa H; Tohda S; Tomiyama J; Nagata K; Tanikawa S
    Exp Hematol; 1995 Aug; 23(9):1030-4. PubMed ID: 7543415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hematopoietic growth factor stimulation and cytarabine cytotoxicity in vitro: effects in untreated and relapsed or primary refractory acute myeloid leukemia cells.
    te Boekhorst PA; Löwenberg B; Sonneveld P
    Leukemia; 1994 Sep; 8(9):1480-6. PubMed ID: 7522289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential regulation by hematopoietic growth factors of apoptosis and mitosis in acute myeloblastic leukemia cells.
    Murohashi I; Yoshida K; Handa A; Murayoshi M; Yoshida S; Jinnai I; Bessho M; Hirashima K
    Exp Hematol; 1997 Sep; 25(10):1042-50. PubMed ID: 9293901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human stem cell factor-antibody [anti-SCF] enhances chemotherapy cytotoxicity in human CD34+ resistant myeloid leukaemia cells.
    Lu C; Hassan HT
    Leuk Res; 2006 Mar; 30(3):296-302. PubMed ID: 16112192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of recombinant human stem cell factor on mafosfamide-treated bone marrow clonogenic cells.
    Carlo-Stella C; Mangoni L; Almici C; Caramatti C; Rizzoli V
    Stem Cells; 1993 Jul; 11 Suppl 2():170-4. PubMed ID: 7691323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of recombinant human stem cell factor (rhSCF) on self-renewal of stem/progenitor cells of human acute myelogenous leukemia].
    Tang JS; Li CY; Wang BM
    Zhonghua Zhong Liu Za Zhi; 1994 Jul; 16(4):259-62. PubMed ID: 7528655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aberrant growth of granulocyte-macrophage progenitors in juvenile chronic myelogenous leukemia in serum-free culture.
    Sawai N; Koike K; Ito S; Okumura N; Kamijo T; Shiohara M; Amano Y; Tsuji K; Nakahata T; Oda M
    Exp Hematol; 1996 Feb; 24(2):116-22. PubMed ID: 8641332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of stem cell factor (c-kit ligand), granulocyte-macrophage colony stimulating factor and interleukin 3 on hematopoietic progenitors in human long-term bone marrow cultures.
    Lemoli RM; Gulati SC
    Stem Cells; 1993 Sep; 11(5):435-44. PubMed ID: 7694721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The in vitro growth patterns and drug sensitivities of leukemic blast progenitors among the subtypes of acute myelocytic leukemia.
    Nara N; Chen GJ; Murohashi I; Tohda S; Imai Y; Tomiyama J; Nagata K; Suzuki T; Tanikawa S; Shiina S
    Exp Hematol; 1992 Aug; 20(7):904-8. PubMed ID: 1628709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hydrocortisone in culture protects the blast cells in acute myeloblastic leukemia from the lethal effects of cytosine arabinoside.
    Yang GS; Wang C; Minkin S; Minden MD; McCulloch EA
    J Cell Physiol; 1991 Jul; 148(1):60-7. PubMed ID: 1860896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effects of TGF-beta 1 on normal and leukemic human hematopoietic cell proliferation.
    Murohashi I; Endho K; Nishida S; Yoshida S; Jinnai I; Bessho M; Hirashima K
    Exp Hematol; 1995 Aug; 23(9):970-7. PubMed ID: 7543418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transforming growth factor-beta 1 interferes with the proliferation-inducing activity of stem cell factor in myelogenous leukemia blasts through functional down-regulation of the c-kit proto-oncogene product.
    de Vos S; Brach MA; Asano Y; Ludwig WD; Bettelheim P; Gruss HJ; Herrmann F
    Cancer Res; 1993 Aug; 53(15):3638-42. PubMed ID: 7687925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of TNFalpha on the growth and sensitivity to cytosine arabinoside of blast progenitors in acute myelogenous leukemia with special reference to the role of NF-kappaB.
    Wu Z; Shen L; Inatomi Y; U M; Miyashita T; Toyama K; Miyauchi J
    Leuk Res; 2003 Nov; 27(11):1009-18. PubMed ID: 12859994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytotoxicity of 4-hydroperoxycyclophosphamide for the blast progenitors of acute myeloblastic leukemia.
    Nara N; Suzuki T; Yamashita Y; Murohashi I; Aoki N
    Cancer Res; 1988 May; 48(9):2348-52. PubMed ID: 3162711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of lineage-negative blast subpopulations derived from normal and chronic myelogenous leukemia bone marrows and determination of their responsiveness to human c-kit ligand.
    Strife A; Perez A; Lambek C; Wisniewski D; Bruno S; Darzynkiewicz Z; Clarkson B
    Cancer Res; 1993 Jan; 53(2):401-9. PubMed ID: 7678076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.